-
公开(公告)号:US5604234A
公开(公告)日:1997-02-18
申请号:US529862
申请日:1995-09-18
申请人: Yat S. Or , Jay R. Luly
发明人: Yat S. Or , Jay R. Luly
IPC分类号: C07D487/14 , C07D491/20 , C07D498/04 , C07D498/14 , C07D498/18 , C07D498/22 , C07D513/14 , C07D513/18 , C07F7/18 , C07F9/6561 , C07H19/01 , A61K31/395 , A61K31/695 , C07D191/16
CPC分类号: C07D498/18 , C07D487/14 , C07D513/14 , C07F7/1856 , C07F9/6561 , C07H19/01
摘要: Immunomodulatory macrocyclic compounds having the formula: ##STR1## and pharmaceutically acceptable salts, esters, amides and prodrugs thereof, as well as pharmaceutical compositions containing such compounds and therapeutic methods of their use.
摘要翻译: 具有下式的免疫调节大环化合物及其药学上可接受的盐,酯,酰胺和前药,以及含有这些化合物的药物组合物及其用途的治疗方法。
-
2.
公开(公告)号:US5599927A
公开(公告)日:1997-02-04
申请号:US573610
申请日:1995-12-15
申请人: Yat S. Or , Jay R. Luly
发明人: Yat S. Or , Jay R. Luly
IPC分类号: C07D498/18 , C07H19/01 , C07D496/12 , A61K31/33
CPC分类号: C07D498/18 , C07H19/01
摘要: Novel macrolide compounds of the formula ##STR1## and pharmaceutically acceptable salts, esters, amides and prodrugs thereof, wherein X is a substituent selected from among radicals having the subformulae ##STR2## and other heterocyclic radicals, as well as pharmaceutical compositions and methods of immunomodulatory treatment utilizing the same.
摘要翻译: 式(II)的新型大环内酯类化合物及其药学上可接受的盐,酯,酰胺和前药,其中X是选自具有子式(IIa)(IIe)(IIe) (IIj)(IIk)和其它杂环基,以及使用其的免疫调节处理的药物组合物和方法。
-
公开(公告)号:US5541193A
公开(公告)日:1996-07-30
申请号:US466302
申请日:1995-06-06
申请人: Megumi Kawai , Yat S. Or , Jay R. Luly
发明人: Megumi Kawai , Yat S. Or , Jay R. Luly
IPC分类号: C07D487/14 , C07D491/20 , C07D498/04 , C07D498/14 , C07D498/18 , C07D498/22 , C07D513/14 , C07D513/18 , C07F7/18 , C07F9/6561 , C07H19/01 , C07D491/18 , A61K31/395
CPC分类号: C07D487/14 , C07D513/14 , C07F7/1856 , C07F9/6561 , C07H19/01
摘要: Immunomodulatory macrocyclic compounds having the formula ##STR1## and pharmaceutically acceptable salts, esters, amides and prodrugs thereof, wherein one of R.sup.107, R.sup.108, R.sup.109 and R.sup.110 is a radical having the formula ##STR2## as well as pharmaceutically compositions containing such compounds and methods of immunomodulatory therapy utilizing the same.
摘要翻译: 具有式“IMAGE”的免疫调节大环化合物及其药学上可接受的盐,酯,酰胺和前药,其中R107,R108,R109和R110之一是具有下式的基团:(III)或 (IV)以及含有这些化合物的药物组合物和利用其的免疫调节治疗方法。
-
公开(公告)号:US5527907A
公开(公告)日:1996-06-18
申请号:US327391
申请日:1994-10-26
申请人: Yat S. Or , Jay R. Luly , Rolf Wagner
发明人: Yat S. Or , Jay R. Luly , Rolf Wagner
IPC分类号: C07D498/18 , C07D491/16 , A61K31/395
CPC分类号: C07D498/18
摘要: Novel macrolide compounds of the formula ##STR1## and pharmaceutically acceptable salts, esters, amides and prodrugs thereof, processes for the preparation of the compounds of the invention, intermediates useful in these processes, a pharmaceutical composition, and a method of treating immunomodulatory disorders are disclosed.
摘要翻译: 下式的新型大环内酯类化合物及其药学上可接受的盐,酯,酰胺和前药,本发明化合物的制备方法,用于这些方法的中间体,药物组合物和治疗免疫调节性疾病的方法是 披露
-
公开(公告)号:US5508397A
公开(公告)日:1996-04-16
申请号:US357568
申请日:1994-12-16
申请人: Yat S. Or , Jay R. Luly
发明人: Yat S. Or , Jay R. Luly
IPC分类号: A61K31/435 , A61P37/06 , C07D498/18 , C07F7/18 , C07D498/16 , C12P17/18
CPC分类号: C07D498/18 , C07F7/1856
摘要: Activated macrolactam compounds having the formula ##STR1## wherein n is zero or one, R.sup.101 is selected from the group consisting of methyl, ethyl, allyl, propyl and cyclopropylmethyl;R.sup.102 is hydrogen, and R.sup.103 is selected from the group consisting of hydrogen, hydroxy and a protected hydroxy group or, taken together, R.sup.102 and R.sup.103 form a bond;R.sup.104 and R.sup.105 are chosen such that one is hydrogen while the other is -OS(O).sub.2 F; andR.sup.106 is selected from the group consisting of hydrogen, a protected hydroxy group, loweralkyl, alkenyl, cycloalkyl, aryl and arylalkyl,as well as processes for making such compounds and methods for their use in the preparation of C-32-modified derivatives of ascomycin or the congeners or analogs thereof.
摘要翻译: 具有式“IMAGE”的活性大环内酰胺化合物,其中n为0或1,R 101选自甲基,乙基,烯丙基,丙基和环丙基甲基; R 102是氢,R 103选自氢,羟基和保护的羟基,或者R 102和R 103一起形成一个键; 选择R104和R105使得一个是氢,而另一个是-OS(O)2 F; R 106选自氢,保护的羟基,低级烷基,烯基,环烷基,芳基和芳基烷基,以及制备这些化合物的方法及其用于制备C-32修饰的衍生物的方法 子囊霉素或其同系物或类似物。
-
公开(公告)号:US5457111A
公开(公告)日:1995-10-10
申请号:US149416
申请日:1993-11-09
申请人: Jay R. Luly , Megumi Kawai , Yat S. Or , Paul Wiedeman , Rolf Wagner
发明人: Jay R. Luly , Megumi Kawai , Yat S. Or , Paul Wiedeman , Rolf Wagner
IPC分类号: C07D487/14 , C07D491/20 , C07D498/04 , C07D498/14 , C07D498/18 , C07D498/22 , C07D513/14 , C07D513/18 , C07F7/18 , C07F9/6561 , C07H19/01 , A61K31/435
CPC分类号: C07D498/18 , C07D487/14 , C07D513/14 , C07F7/1856 , C07F9/6561 , C07H19/01
摘要: Immunomodulatory macrocyclic compounds having the formula ##STR1## and pharmaceutically acceptable salts, esters, amides and prodrugs thereof, wherein X is selected from one of the formulae ##STR2## as well as pharmaceutical compositions containing the same.
摘要翻译: 具有下式(VII)的免疫调节大环化合物及其药学上可接受的盐,酯,酰胺和前药,其中X选自下列之一:IMAGE< IMAGE>以及含有该化合物的药物组合物。
-
公开(公告)号:US5386011A
公开(公告)日:1995-01-31
申请号:US634641
申请日:1990-12-27
申请人: Paul E. Wiedeman , Megumi Kawai , Jay R. Luly , Yat S. Or , Rolf Wagner
发明人: Paul E. Wiedeman , Megumi Kawai , Jay R. Luly , Yat S. Or , Rolf Wagner
IPC分类号: A61K38/00 , A61P37/08 , C07K5/02 , C07K5/06 , C07K5/08 , C07K5/10 , C07K7/02 , C07K7/06 , C07K14/47 , A61K37/00 , C07K5/00 , C07K7/00 , A61K37/02
CPC分类号: C07K14/472 , A61K38/00
摘要: Oligopeptide compounds or oligopeptide analogue compounds of the formula A-B-D-E-G-J-L-M-Q are ligands for the anaphylatoxin receptor and are useful in the treatment of inflammatory disease states.Also disclosed are anaphylatoxin receptor ligand compositions and a method for modulating anaphylatoxin activity.
摘要翻译: 式A-B-D-E-G-J-L-M-Q的寡肽化合物或寡肽类似物化合物是过敏毒素受体的配体,可用于治疗炎性疾病状态。 还公开了过敏毒素受体配体组合物和调节过敏毒素活性的方法。
-
公开(公告)号:US07273851B2
公开(公告)日:2007-09-25
申请号:US10849107
申请日:2004-05-19
申请人: Zhenwei Miao , Ying Sun , Suanne Nakajima , Datong Tang , Zhe Wang , Yat S. Or
发明人: Zhenwei Miao , Ying Sun , Suanne Nakajima , Datong Tang , Zhe Wang , Yat S. Or
IPC分类号: A61K38/00
CPC分类号: C07K5/0808 , A61K38/00
摘要: The present invention relates to compounds of Formula I, or a pharmaceutically acceptable salt, ester, or prodrug, thereof: which inhibit serine protease activity, particularly the activity of hepatitis c virus (HCV) NS3-NS4A protease. Consequently, the compounds of the present invention interfere with the life cycle of the hepatitis c virus and are also useful as antiviral agents. The present invention further relates to pharmaceutical compositions comprising the aforementioned compounds for administration to a subject suffering from HCV infection. The invention also relates to methods of treating an HCV infection in a subject by administering a pharmaceutical composition comprising the compounds of the present invention.
摘要翻译: 本发明涉及抑制丝氨酸蛋白酶活性,特别是丙型肝炎病毒(HCV)NS3-NS4A蛋白酶活性的式I化合物或其药学上可接受的盐,酯或前药。 因此,本发明的化合物干扰丙型肝炎病毒的生命周期,也可用作抗病毒剂。 本发明还涉及药物组合物,其包含用于给患有HCV感染的受试者施用的上述化合物。 本发明还涉及通过施用包含本发明化合物的药物组合物来治疗受试者的HCV感染的方法。
-
9.
公开(公告)号:US5612350A
公开(公告)日:1997-03-18
申请号:US424912
申请日:1995-04-19
申请人: Yat S. Or , Jay R. Luly
发明人: Yat S. Or , Jay R. Luly
IPC分类号: C07D498/18 , C07H19/01 , A61K31/395
CPC分类号: C07D498/18 , C07H19/01
摘要: Novel macrolide compounds of the formula ##STR1## and pharmaceutically acceptable salts, esters, amides and prodrugs thereof, wherein X is a substituent selected from among radicals having the subformulae ##STR2## and other heterocyclic radicals, as well as pharmaceutical compositions and methods of immunomodulatory treatment utilizing the same.
摘要翻译: 式(II)的新型大环内酯类化合物及其药学上可接受的盐,酯,酰胺和前药,其中X是选自具有子式(IIa)(IIe)(IIe) >(IIj)和
(IIk)和其它杂环基,以及使用其的免疫调节治疗的药物组合物和方法。 -
公开(公告)号:US5561228A
公开(公告)日:1996-10-01
申请号:US204252
申请日:1994-03-07
申请人: Yat S. Or , Jay R. Luly , Megumi Kawai , Rolf Wagner , Paul E. Wiedeman
发明人: Yat S. Or , Jay R. Luly , Megumi Kawai , Rolf Wagner , Paul E. Wiedeman
IPC分类号: A61K31/435 , A61K31/365 , A61P1/00 , A61P17/00 , A61P17/06 , A61P17/08 , A61P17/14 , A61P21/04 , A61P29/00 , A61P37/06 , C07D487/14 , C07D491/056 , C07D491/08 , C07D491/153 , C07D491/18 , C07D491/20 , C07D498/04 , C07D498/08 , C07D498/14 , C07D498/18 , C07D498/22 , C07D513/14 , C07D513/18 , C07F7/18 , C07F9/6561 , C07H19/01 , C12P17/16 , C12R1/465 , C07D498/16 , A61K31/695
CPC分类号: C07D487/14 , C07D513/14 , C07F7/1856 , C07F9/6561 , C07H19/01
摘要: Immunomodulatory macrocyclic compounds having the formula ##STR1## and pharmaceutically acceptable salts, esters, amides and prodrugs thereof, wherein X is a group having the formula ##STR2## as well as pharmaceutical compositions containing the same.
摘要翻译: PCT No.PCT / US92 / 07593 Sec。 371日期:1994年3月7日 102(e)1994年3月7日PCT PCT 1992年9月8日PCT公布。 公开号WO93 / 04679 日期1993年3月18日具有式(VII)的免疫调节大环化合物及其药学上可接受的盐,酯,酰胺和前药,其中X是具有式(Ic)的基团以及含有 相同。
-
-
-
-
-
-
-
-
-